Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism. 2011

Chien-Te Lee, and Hwee-Yeong Ng, and Yeong-Hau Lien, and Li-Wen Lai, and Mai-Szu Wu, and Chung-Ren Lin, and Hung-Chun Chen
Division of Nephrology, Department of Medicine, Chang-Gung Memorial Hospital, Kaohsiung Medical Center, Chang-Gung University College of Medicine, Gueishan, Taiwan, ROC.

BACKGROUND Abnormalities in mineral metabolism are common complications of organ transplantation. The role of immunosuppressive agents in alteration of mineral metabolism is not clear. METHODS We conducted an animal study to investigate the effects of cyclosporine A (CsA), tacrolimus, and sirolimus on renal calcium, magnesium and vitamin D metabolism. RESULTS CsA and tacrolimus induced a 2- to 3-fold and 1.6- to 1.8-fold increase in urinary calcium and magnesium excretion, respectively, while rapamycin had no effects on calcium, but doubled the urinary magnesium excretion. CsA and tacrolimus, but not rapamycin, elevated serum 1,25(OH)(2) vitamin D without affecting the parathyroid hormone level. CsA and tacrolimus reduced mRNA abundance in TRPV5 (CsA: 64 ± 3% of control; tacrolimus: 50 ± 3%) calbindin-D28k (CsA: 62 ± 4%; tacrolimus: 43 ± 3%), and vitamin D receptor (CsA: 52 ± 3%; tacrolimus: 58 ± 2%, all p < 0.05). Rapamycin did not affect gene expression in any of studied proteins. The immunofluorescence staining study demonstrated a 50% reduction of TRPV5 and calbindin-D28k by CsA and tacrolimus. CONCLUSIONS The suppression of VDR by calcineurin inhibitors is probably the underlying mechanism of renal calcium wasting. In spite of an increased 1,25(OH)(2) vitamin D level, the kidney is not able to reserve calcium, suggesting a role of vitamin D resistance that may be related to bone loss.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014807 Vitamin D A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.
D015220 Calcium Channels Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue. Ion Channels, Calcium,Receptors, Calcium Channel Blocker,Voltage-Dependent Calcium Channel,Calcium Channel,Calcium Channel Antagonist Receptor,Calcium Channel Antagonist Receptors,Calcium Channel Blocker Receptor,Calcium Channel Blocker Receptors,Ion Channel, Calcium,Receptors, Calcium Channel Antagonist,VDCC,Voltage-Dependent Calcium Channels,Calcium Channel, Voltage-Dependent,Calcium Channels, Voltage-Dependent,Calcium Ion Channel,Calcium Ion Channels,Channel, Voltage-Dependent Calcium,Channels, Voltage-Dependent Calcium,Voltage Dependent Calcium Channel,Voltage Dependent Calcium Channels
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

Chien-Te Lee, and Hwee-Yeong Ng, and Yeong-Hau Lien, and Li-Wen Lai, and Mai-Szu Wu, and Chung-Ren Lin, and Hung-Chun Chen
November 2017, Transplantation proceedings,
Chien-Te Lee, and Hwee-Yeong Ng, and Yeong-Hau Lien, and Li-Wen Lai, and Mai-Szu Wu, and Chung-Ren Lin, and Hung-Chun Chen
July 1994, Current opinion in nephrology and hypertension,
Chien-Te Lee, and Hwee-Yeong Ng, and Yeong-Hau Lien, and Li-Wen Lai, and Mai-Szu Wu, and Chung-Ren Lin, and Hung-Chun Chen
July 1990, Journal of the American Society of Nephrology : JASN,
Chien-Te Lee, and Hwee-Yeong Ng, and Yeong-Hau Lien, and Li-Wen Lai, and Mai-Szu Wu, and Chung-Ren Lin, and Hung-Chun Chen
July 2003, Clinical calcium,
Chien-Te Lee, and Hwee-Yeong Ng, and Yeong-Hau Lien, and Li-Wen Lai, and Mai-Szu Wu, and Chung-Ren Lin, and Hung-Chun Chen
January 2007, The Journal of steroid biochemistry and molecular biology,
Chien-Te Lee, and Hwee-Yeong Ng, and Yeong-Hau Lien, and Li-Wen Lai, and Mai-Szu Wu, and Chung-Ren Lin, and Hung-Chun Chen
March 1994, Seminars in nephrology,
Chien-Te Lee, and Hwee-Yeong Ng, and Yeong-Hau Lien, and Li-Wen Lai, and Mai-Szu Wu, and Chung-Ren Lin, and Hung-Chun Chen
August 1987, The American journal of clinical nutrition,
Chien-Te Lee, and Hwee-Yeong Ng, and Yeong-Hau Lien, and Li-Wen Lai, and Mai-Szu Wu, and Chung-Ren Lin, and Hung-Chun Chen
April 1978, Annals of the New York Academy of Sciences,
Chien-Te Lee, and Hwee-Yeong Ng, and Yeong-Hau Lien, and Li-Wen Lai, and Mai-Szu Wu, and Chung-Ren Lin, and Hung-Chun Chen
December 1991, Kidney international,
Chien-Te Lee, and Hwee-Yeong Ng, and Yeong-Hau Lien, and Li-Wen Lai, and Mai-Szu Wu, and Chung-Ren Lin, and Hung-Chun Chen
August 1984, The Journal of clinical investigation,
Copied contents to your clipboard!